Articles From: Rebecca Tadikonda to Join MetLife as Chief Enterprise Strategy Officer to Red Giant Entertainment to Give Away Nearly 100,000 Ad-Supported Comic Books for Comic-Con International: San Diego


MetLife, Inc. (NYSE: MET) announced today that Rebecca Tadikonda will join the company as chief enterprise strategy officer effective July 21, 2014.
Sign-up for Rebecca Tadikonda to Join MetLife as Chief Enterprise Strategy Officer investment picks
Whole Foods Market (NASDAQ: WFM), the world’s leading natural and organic foods supermarket, is launching Wine Club by Whole Foods Market on Oct.
Sign-up for Receive Exceptional Wines Delivered to Your Front Door with New Wine Club by Whole Foods Market® investment picks
American Vanguard Corporation (NYSE:AVD) today announced that lower than normal purchasing of corn inputs and reduced production levels at the Company’s manufacturing facilities will affect second quarter 2014 financial performance.
Sign-up for Recent Agricultural Purchasing Patterns and Lower Factory Utilization Rates Will Affect American Vanguard’s Second Quarter 2014 Financial Performance investment picks
2014/9/3
Utility Participates in Several Community Events throughout the Month to Share Safety and Preparedness Information and Demonstrate Gas and Electric Hazards with Customers SAN FRANCISCO , Sept.
Sign-up for Recent Earthquake in Napa County Reminder to PG&E Customers to "Be Prepared" During National Preparedness Month investment picks
SAN DIEGO, July 29, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, today announced the appointment of Mary Szela and Richard Heyman to the board of directors of Receptos.
Sign-up for Receptos Announces Appointment of Mary Szela and Richard Heyman, Ph.D. to Board of Directors investment picks
SAN DIEGO, June 24, 2014 (GLOBE NEWSWIRE) -- Receptos, Inc. (Nasdaq:RCPT) , a biopharmaceutical company developing therapeutic candidates for the treatment of immune and metabolic diseases, announced today closing of the previously announced underwritten public offering of 4,433,000 shares of its common stock at a price to the public of $40.25 per share.
Sign-up for Receptos Announces Closing of Underwritten Public Offering of Common Stock investment picks
Detailed Results of Positive Phase 2 Trial of RPC1063 in Relapsing Multiple Sclerosis to be Presented at Late Breaker Session on September 13, 2014 SAN DIEGO, Sept.
Sign-up for Receptos Announces Oral Podium Presentation at MS Boston 2014 investment picks
Completes enrollment of Phase 2 trial of RPC1063 in Ulcerative Colitis; data expected in fourth quarter of 2014 SAN DIEGO, Aug.
Sign-up for Receptos Reports Second Quarter 2014 Financial Results investment picks
SAN DIEGO, Aug.
Sign-up for Receptos to Present at Wedbush PacGrow Life Sciences Conference investment picks
2014/7/28
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- Shares of Reckitt Benckiser Group PLC led the U.K.'s FTSE 100 index to a strong start to the week, after the consumer-product company said it plans to spin off a division.
Sign-up for Reckitt Benckiser leads U.K.'s FTSE 100 higher investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0960121001&sourceType=1 http://www.ccnmatthews.com/logos2/Fortis_L.gif ST.
Sign-up for Recommended Order Finds Fortis Inc. Acquisition of UNS Energy Corporation is in the Public Interest, Recommends Approval investment picks
Partnering With ABB Seen As Enhancing Growth Prospects by Expanding Products and Services Offerings BEIJING , Aug.
Sign-up for Recon Qualifies As Authorized ABB Third Party System Integrator investment picks
Audited Fiscal Year 2014 Results Expected To Be Announced on September 29, 2014 BEIJING , Sept.
Sign-up for Recon Technology Expects to Report Sales in FY2014 Grew More Than 20% Year over Year as Sales of Furnaces and Automation Products to Oilfield Customers More Than Doubled; Company Also Anticipates Healthy Gain in Net Income and Adjusted Net Income Attributable to Shareholders investment picks
FY 2014 Results Were Boosted By Sharp Increases in Oilfield Automation and Furnaces Revenues, Improved Gross Margins, and an Operating Profit Versus Operating Loss in the Prior Year BEIJING , Sept.
Sign-up for Recon Technology Reports Strong Gains in FY 2014 and Announces Growth Goals investment picks
BEIJING , July 22, 2014 /PRNewswire/ -- Recon Technology (NASDAQ: RCON) , a leading independent oilfield services provider operating primarily in China , today announced that it has strengthened its communication team with the addition of two bilingual staffers with American educational backgrounds who will report to Ms.
Sign-up for Recon Technology Strengthens Communications Team investment picks
By Lawrence G.
Sign-up for Record 200-day moving average due for a fall investment picks
http://media.marketwire.com/attachments/201403/235171_apptech_logo_v2.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148726&ProfileId=051205&sourceType=1 CARLSBAD, CA --
Sign-up for Record Date for Special General Meeting of Shareholders investment picks
MONTE CARLO, Monaco , Sept.
Sign-up for Record reinsurance capacity drives growth capital for insurers: Aon Benfield outlook report investment picks
Guest Spending Per Capita Rises Ten Percent in First Half of 2014 While Active Pass Base Grows 9 Percent GRAND PRAIRIE, Texas , July 21, 2014 /PRNewswire/ -- Six Flags Entertainment Corporation (NYSE: SIX) , the world's largest regional theme park company, today announced record financial performance in the second quarter 2014 as revenue grew $13 million or 4 percent to $377 million , fueled by higher guest spending.
Sign-up for Record Revenue and Earnings in the Second Quarter at Six Flags investment picks
NEW YORK, July 7, 2014 (GLOBE NEWSWIRE) -- The largest ever volume of non-life catastrophe bonds was issued during the second quarter of 2014 (Q2), according to a report by Willis Capital Markets & Advisory (WCMA), part of Willis Group Holdings plc (NYSE:WSH) , the global risk advisor, insurance and reinsurance broker.
Sign-up for Record Volume of Cat Bonds Issued in Q2 2014 - Willis Capital Markets & Advisory investment picks
MALVERN, Pa., June 30, 2014 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH) , a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, initially for acute pain following surgery, today announced that it was added to the Russell Microcap ® Index following market close on June 27, 2014.
Sign-up for Recro Pharma Added to Russell Microcap(R) Index investment picks
Analgesia in a subset of patients (50%), suggests therapeutic potential for Dex-IN in Post Op Day 1 MALVERN, Pa., Sept.
Sign-up for Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN investment picks
MALVERN, Pa., Aug.
Sign-up for Recro Pharma Reports Second Quarter 2014 Financial Results investment picks
MALVERN, Pa., Sept.
Sign-up for Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference investment picks
Believes ClubCorp is Meaningfully Undervalued and has a Unique Opportunity to Maximize Value for all Shareholders Urges ClubCorp to Move Immediately to Evaluate and Implement Conversion to a REIT and Spin-Off of Non-Real Estate Assets Calls Upon the Board to Form a Special Committee to Explore Restructuring that is in the Best Interests of All Shareholders Believes ClubCorp Could be Conservatively Worth Between $31 (No Incremental Leverage) and $36 (Appropriate Leverage) per Share upon Restructuring NEW YORK , Sept.
Sign-up for Red Alder Group Delivers Letter to Board of ClubCorp Holdings Urging Pursuit of Restructuring investment picks
http://media.marketwire.com/attachments/201206/55916_RGEMarketwireLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1132254&ProfileId=051205&sourceType=1 ORLANDO, FL --
Sign-up for Red Giant Entertainment to Give Away Nearly 100,000 Ad-Supported Comic Books for Comic-Con International: San Diego investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Rebecca Tadikonda to Join MetLife as Chief Enterprise Strategy Officer to Red Giant Entertainment to Give Away Nearly 100,000 Ad-Supported Comic Books for Comic-Con International: San Diego
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices